Metformin and cancer in type 2 diabetes.

Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. Autophagy (2015) 0.93

Nutrition and healthy ageing: calorie restriction or polyphenol-rich "MediterrAsian" diet? Oxid Med Cell Longev (2013) 0.93

Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells. Diabetes Metab J (2015) 0.79

The association between metabolic health, obesity phenotype and the risk of breast cancer. Int J Cancer (2017) 0.79

Insulin signaling regulates a functional interaction between Adenomatous Polyposis Coli (APC) and cytoplasmic dynein. Mol Biol Cell (2017) 0.75

Metformin and reduced risk of cancer in diabetic patients. BMJ (2005) 13.04

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia (2009) 10.95

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol (2009) 10.18

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care (2006) 7.99

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res (2009) 6.74

Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care (2009) 6.17

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res (2007) 5.45

Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst (2005) 5.32

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol (2004) 5.29

Diabetes and cancer. Endocr Relat Cancer (2009) 5.04

Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology (2009) 4.72

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab (2010) 4.08

Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) (2012) 4.04

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73

Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care (2010) 3.68

Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther (2010) 2.93

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care (2009) 2.90

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One (2012) 2.84

Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol (2003) 2.52

Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes Control (2009) 2.49

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care (2012) 2.32

Understanding the benefit of metformin use in cancer treatment. BMC Med (2011) 2.28

Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer (2006) 2.09

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia (2010) 2.03

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2008) 2.01

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol (2008) 1.88

Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle (2010) 1.78

Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care (2011) 1.65

Association of metformin use with cancer incidence and mortality: a meta-analysis. Cancer Epidemiol (2013) 1.49

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Ann N Y Acad Sci (2011) 1.34

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care (2010) 1.22

Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies. Metabolism (2013) 1.12

Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control (2012) 1.04

The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res (2011) 1.00

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes. Diabetes Metab J (2013) 0.86

Resistin in rodents and humans. Diabetes Metab J (2013) 1.03

Connecting Myokines and Metabolism. Endocrinol Metab (Seoul) (2015) 0.82